Evaluation of tumor immune contexture among intrinsic molecular subtypes helps to predict outcome in early breast cancer

Background The prognosis of early breast cancer is linked to clinic-pathological stage and the molecular characteristics of intrinsic tumor cells. In some patients, the amount and quality of tumor-infiltrating immune cells appear to affect long term outcome. We aimed to propose a new tool to estimat...

Full description

Bibliographic Details
Main Authors: Valentin Derangere, Quentin Klopfenstein, Marion Thibaudin, Laurent Arnould, Sylvain Ladoire
Format: Article
Language:English
Published: BMJ Publishing Group 2021-06-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/9/6/e002036.full